These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 35833966)
1. All-Atom Simulations of Human ACE2-Spike Protein RBD Complexes for SARS-CoV-2 and Some of its Variants: Nature of Interactions and Free Energy Diagrams for Dissociation of the Protein Complexes. Dutta S; Panthi B; Chandra A J Phys Chem B; 2022 Jul; 126(29):5375-5389. PubMed ID: 35833966 [TBL] [Abstract][Full Text] [Related]
2. All-atom simulations of the trimeric spike protein of SARS-CoV-2 in aqueous medium: Nature of interactions, conformational stability and free energy diagrams for conformational transition of the protein. Panthi B; Dutta S; Chandra A J Comput Chem; 2023 Jun; 44(17):1560-1577. PubMed ID: 37000187 [TBL] [Abstract][Full Text] [Related]
3. Mechanistic insights into the effects of key mutations on SARS-CoV-2 RBD-ACE2 binding. Aggarwal A; Naskar S; Maroli N; Gorai B; Dixit NM; Maiti PK Phys Chem Chem Phys; 2021 Dec; 23(46):26451-26458. PubMed ID: 34806722 [TBL] [Abstract][Full Text] [Related]
4. RBD Double Mutations of SARS-CoV-2 Strains Increase Transmissibility through Enhanced Interaction between RBD and ACE2 Receptor. Sinha S; Tam B; Wang SM Viruses; 2021 Dec; 14(1):. PubMed ID: 35062205 [TBL] [Abstract][Full Text] [Related]
5. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics. Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA Elife; 2021 Aug; 10():. PubMed ID: 34435953 [TBL] [Abstract][Full Text] [Related]
6. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites. Qiao B; Olvera de la Cruz M ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067 [TBL] [Abstract][Full Text] [Related]
7. In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion. Augusto G; Mohsen MO; Zinkhan S; Liu X; Vogel M; Bachmann MF Allergy; 2022 Jan; 77(1):111-117. PubMed ID: 34453338 [TBL] [Abstract][Full Text] [Related]
8. Receptor binding domain of SARS-CoV-2 from Wuhan strain to Omicron B.1.1.529 attributes increased affinity to variable structures of human ACE2. Patil S; Alzahrani KJ; Banjer HJ; Halawani IF; Alzahrani H; Altayar MA; Albogami S; Angeles RF; Hassan AAA; Bhandi S; Raj AT J Infect Public Health; 2022 Jul; 15(7):781-787. PubMed ID: 35738053 [TBL] [Abstract][Full Text] [Related]
9. Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern. Kim S; Liu Y; Lei Z; Dicker J; Cao Y; Zhang XF; Im W J Chem Theory Comput; 2021 Dec; 17(12):7972-7979. PubMed ID: 34856802 [TBL] [Abstract][Full Text] [Related]
10. Tinocordiside from Balkrishna A; Pokhrel S; Varshney A Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372 [TBL] [Abstract][Full Text] [Related]
11. Electrostatic Interactions Are the Primary Determinant of the Binding Affinity of SARS-CoV-2 Spike RBD to ACE2: A Computational Case Study of Omicron Variants. Sang P; Chen YQ; Liu MT; Wang YT; Yue T; Li Y; Yin YR; Yang LQ Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499120 [TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis of the differences in the binding profile of the wild-type and mutants of the SARS-CoV-2 spike protein variants with the ACE2 receptor. Suleman M; Yousafi Q; Ali J; Ali SS; Hussain Z; Ali S; Waseem M; Iqbal A; Ahmad S; Khan A; Wang Y; Wei DQ Comput Biol Med; 2021 Nov; 138():104936. PubMed ID: 34655895 [TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulations highlight the altered binding landscape at the spike-ACE2 interface between the Delta and Omicron variants compared to the SARS-CoV-2 original strain. Pitsillou E; Liang JJ; Beh RC; Hung A; Karagiannis TC Comput Biol Med; 2022 Oct; 149():106035. PubMed ID: 36055162 [TBL] [Abstract][Full Text] [Related]
14. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context. Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687 [TBL] [Abstract][Full Text] [Related]
15. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor. Lata S; Akif M J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980 [TBL] [Abstract][Full Text] [Related]
16. Mechanistic Origin of Different Binding Affinities of SARS-CoV and SARS-CoV-2 Spike RBDs to Human ACE2. Zhang ZB; Xia YL; Shen JX; Du WW; Fu YX; Liu SQ Cells; 2022 Apr; 11(8):. PubMed ID: 35455955 [TBL] [Abstract][Full Text] [Related]
17. Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants. da Costa CHS; de Freitas CAB; Alves CN; Lameira J Sci Rep; 2022 May; 12(1):8540. PubMed ID: 35595778 [TBL] [Abstract][Full Text] [Related]
18. Investigation on the interaction mechanism of different SARS-CoV-2 spike variants with hACE2: insights from molecular dynamics simulations. Wu J; Zhang HX; Zhang J Phys Chem Chem Phys; 2023 Jan; 25(3):2304-2319. PubMed ID: 36597957 [TBL] [Abstract][Full Text] [Related]
19. Key residues of the receptor binding domain in the spike protein of SARS-CoV-2 mediating the interactions with ACE2: a molecular dynamics study. Yang Y; Zhang Y; Qu Y; Zhang C; Liu XW; Zhao M; Mu Y; Li W Nanoscale; 2021 May; 13(20):9364-9370. PubMed ID: 33999091 [TBL] [Abstract][Full Text] [Related]
20. Understanding the molecular interaction of SARS-CoV-2 spike mutants with ACE2 (angiotensin converting enzyme 2). Istifli ES; Netz PA; Sihoglu Tepe A; Sarikurkcu C; Tepe B J Biomol Struct Dyn; 2022; 40(23):12760-12771. PubMed ID: 34495817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]